Among a total of 82,140 subjects of 11 RCTs, they found that GLP1-RAs demonstrated a 16% relative reduction in stroke compared with placebo.101 Such finding supports that GLP-1RA prevents CVD even in those without diabetes, which may explain at least partially the potential cognitive benefits of GLP-1RA. Here, GLP1R is linked to stroke disorder.